EcoDrugPlus

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSSDUG00000011695
Gene Symbol: LOC111223824
3 Cross references
203 Possible Orthologues:

Proteasome Subunit Beta Type-6-Like

Ensembl ID : ENSSDUG00000014051
Gene Symbol: LOC111239148
3 Cross references
230 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSSDUG00000021536
Gene Symbol: LOC111221130
3 Cross references
171 Possible Orthologues:

Proteasome Subunit Beta Type-9

Ensembl ID : ENSSDUG00000022921
Gene Symbol: LOC111239430
3 Cross references
208 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSSDUG00000011753
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSSDUG00000005661
Gene Symbol: LOC111216443
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSSDUG00000018185
Gene Symbol: PRKCA
4 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSSDUG00000015271
Gene Symbol: PRKCB
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type-Like

Ensembl ID : ENSSDUG00000017301
Gene Symbol: LOC111216674
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSDUG00000021793
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSDUG00000007800
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSDUG00000015074
Gene Symbol: PRKCE
3 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).